In this study, we observed that KRAS mutation frequency in pancreatic tumors was consistent with ours and other previous European studies that were based on 70–100 tumors and reported a mutation frequency of 72–83% [14], [16], [17]. The gene discussed is KRAS; the disease is pancreatic neoplasm.